Winning Together

The information in these press releases is accurate only as of the date of the particular press release. Theravance does not update press releases once they have been made public. Press releases may contain forward-looking statements and future events or actual results could differ materially from those projected in the forward-looking statements.

All Releases

	Theravance Announces Positive Results from a Phase 2a Study of its LAMA Candidate, TD-4208, for the Treatment of COPD Nov 14, 2011	132.6 KB
	Theravance to Present at Investor Conferences in November 2011 Nov 1, 2011	26.6 KB
	Theravance Reports Third Quarter 2011 Financial Results Oct 27, 2011	81.1 KB
	Theravance Announces Presentation of GSK Phase 2 Data for LAMA (GSK573719) at CHEST 2011 Oct 19, 2011	18.7 KB
	Theravance to Report Third Quarter 2011 Financial Results on October 27, 2011 Oct 13, 2011	20.8 KB
	Astellas and Theravance Announce European Marketing Authorization for VIBATIV( R ) for Nosocomial Pneumonia Caused by MRSA Sep 15, 2011	84.6 KB
	Theravance to Present at Investor Conferences in September 2011 Aug 24, 2011	19.7 KB
	Theravance Reports Second Quarter 2011 Financial Results Jul 28, 2011	79.2 KB
	Theravance to Report Second Quarter 2011 Financial Results on July 28, 2011 Jul 14, 2011	20.9 KB
	GSK and Theravance announce results of two pivotal Phase III studies for RelovairTM in COPD Jun 2, 2011	116.5 KB
	Theravance to Present at Investor Conferences in June 2011 May 24, 2011	25.3 KB
	Astellas and Theravance Receive Positive Opinion from CHMP for European Approval of VIBATIV( TM ) for Nosocomial Pneumonia Caused by MRSA May 20, 2011	99.5 KB
	Theravance Reports First Quarter 2011 Financial Results Apr 28, 2011	106.4 KB
	Theravance to Webcast 2011 Annual Meeting of Stockholders on April 27, 2011 Apr 20, 2011	62.7 KB
	Theravance to Present at Investor Conferences in May 2011 Apr 19, 2011	25.4 KB
	Theravance to Report First Quarter 2011 Financial Results on April 28, 2011 Apr 14, 2011	22.3 KB
	Theravance to Present at Investor Conferences in March 2011 Feb 16, 2011	25.3 KB
	Theravance Reports Fourth Quarter and Full Year 2010 Financial Results Feb 15, 2011	45.3 KB
	GSK and Theravance announce progression of LAMA/LABA combination treatment into Phase III development for COPD; Relovair(TM ) programme expanded by start of large Phase IIIb COPD outcomes study Feb 3, 2011	240.1 KB
	Theravance to Report Fourth Quarter and Full Year 2010 Financial Results on February 15, 2011 Feb 1, 2011	22.4 KB
Showing 61-80 of 150 Page: 1 2 3 4 5 6 7 8  Previous 20 | Next 20

= add release to Briefcase